BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 7553660)

  • 21. Expression of CD44 isoforms in human breast carcinoma xenografts is not influenced by the treatment of mice with cytostatics or (anti-)hormones.
    Dehmel A; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1999; 19(3A):1977-87. PubMed ID: 10470143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD44 is expressed in hepatocellular carcinomas showing vascular invasion.
    Mathew J; Hines JE; Obafunwa JO; Burr AW; Toole K; Burt AD
    J Pathol; 1996 May; 179(1):74-9. PubMed ID: 8691349
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study.
    Morris SF; O'Hanlon DM; McLaughlin R; McHale T; Connolly GE; Given HF
    Eur J Surg Oncol; 2001 Sep; 27(6):527-31. PubMed ID: 11520083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression and prognostic value Of CD44 isoforms in nephroblastoma (Wilms tumor).
    Ghanem MA; Van Steenbrugge GJ; Van Der Kwast TH; Sudaryo MK; Noordzij MA; Nijman RJ
    J Urol; 2002 Aug; 168(2):681-6. PubMed ID: 12131349
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Splice variant expression of CD44 in patients with breast and ovarian cancer.
    Sanchez Lockhart M; Hajos SE; Basilio FM; Mongini C; Alvarez E
    Oncol Rep; 2001; 8(1):145-51. PubMed ID: 11115587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD44 isoforms in human prostate tumor cell lines.
    Stevens JW; Palechek PL; Griebling TL; Midura RJ; Rokhlin OW; Cohen MB
    Prostate; 1996 Mar; 28(3):153-61. PubMed ID: 8628718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
    Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 isoforms in metastatic cancer.
    Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
    Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of CD44 variant proteins in human colorectal cancer is related to tumor progression.
    Wielenga VJ; Heider KH; Offerhaus GJ; Adolf GR; van den Berg FM; Ponta H; Herrlich P; Pals ST
    Cancer Res; 1993 Oct; 53(20):4754-6. PubMed ID: 7691404
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression in gastric carcinoma relative to the ratio of CD44 epithelial variant transcript to CD44 hematopoietic variant transcript.
    Miwa T; Watanabe A; Yamada Y; Shino Y; Yamada T; Yamashita J; Matsuda M; Nakano H
    Cancer; 1996 Jan; 77(1):25-9. PubMed ID: 8630934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CD44 isoforms during differentiation and development.
    Ruiz P; Schwärzler C; Günthert U
    Bioessays; 1995 Jan; 17(1):17-24. PubMed ID: 7535522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Occurrence of CD44 and its isoforms under orthological and pathological conditions].
    Terpe A; Franke F; Stark H; Gustmann C; Mackay C; Marston W; Günthert U
    Verh Dtsch Ges Pathol; 1993; 77():276-81. PubMed ID: 7511297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Expression of CD44 variant form in human renal cell carcinoma].
    Kanayama H; Kan M; Aki M; Kagawa S
    Nihon Rinsho; 1995 Jul; 53(7):1710-5. PubMed ID: 7630012
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular genetic characterization of alternatively spliced CD44 transcripts in human stomach carcinoma.
    Kim YS; Chi SG; Kim YW; Park YK; Yoon C
    J Korean Med Sci; 1997 Dec; 12(6):505-13. PubMed ID: 9443088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decreased immunoexpression of standard form of CD44 is an independent favourable predictor of nodal metastasis in colorectal carcinoma.
    Al-Maghrabi J; Gomaa W; Buhmeida A; Al-Qahtani M; Al-Ahwal M
    Anticancer Res; 2012 Aug; 32(8):3455-61. PubMed ID: 22843930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD44 variant isoforms are preferentially expressed in basal epithelial of non-malignant human fetal and adult tissues.
    Terpe HJ; Stark H; Prehm P; Günthert U
    Histochemistry; 1994 Feb; 101(2):79-89. PubMed ID: 7520892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD44 isoform expression follows two alternative splicing pathways in breast tissue.
    Roca X; Mate JL; Ariza A; Muñoz-Mármol AM; von Uexküll-Güldeband C; Pellicer I; Navas-Palacios JJ; Isamat M
    Am J Pathol; 1998 Jul; 153(1):183-90. PubMed ID: 9665479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ratio of CD44 epithelial variant to CD44 hematopoietic variant is a useful prognostic indicator in gastric and colorectal carcinoma.
    Shibuya Y; Okabayashi T; Oda K; Tanaka N
    Jpn J Clin Oncol; 1998 Oct; 28(10):609-14. PubMed ID: 9839501
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression and modulation of CD44 variant isoforms in humans.
    Mackay CR; Terpe HJ; Stauder R; Marston WL; Stark H; Günthert U
    J Cell Biol; 1994 Jan; 124(1-2):71-82. PubMed ID: 7507492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD44 variant isoforms in non-Hodgkin's lymphoma: a new independent prognostic factor.
    Stauder R; Eisterer W; Thaler J; Günthert U
    Blood; 1995 May; 85(10):2885-99. PubMed ID: 7537983
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.